98 related articles for article (PubMed ID: 23184735)
21. The structural basis of the autoinhibition mechanism of glycogen synthase kinase 3β (GSK3β): molecular modeling and molecular dynamics simulation studies.
Mou L; Dou W; Meng G; Sun K; Chen X
J Biomol Struct Dyn; 2020 Apr; 38(6):1741-1750. PubMed ID: 31057052
[TBL] [Abstract][Full Text] [Related]
22. Molecular Insights into the Trapping Effect of Ca
Solorza J; Recabarren R; Alzate-Morales J
J Chem Inf Model; 2020 Feb; 60(2):898-914. PubMed ID: 31804819
[TBL] [Abstract][Full Text] [Related]
23. Prediction of the binding mode between GSK3β and a peptide derived from GSKIP using molecular dynamics simulation.
Tang XN; Lo CW; Chuang YC; Chen CT; Sun YC; Hong YR; Yang CN
Biopolymers; 2011 Jul; 95(7):461-71. PubMed ID: 21328310
[TBL] [Abstract][Full Text] [Related]
24. Docking and quantitative structure-activity relationship of oxadiazole derivates as inhibitors of GSK3β.
Quesada-Romero L; Caballero J
Mol Divers; 2014 Feb; 18(1):149-59. PubMed ID: 24081608
[TBL] [Abstract][Full Text] [Related]
25. Binding and stability of indirubin-3-monoxime in the GSK3β enzyme: a molecular dynamics simulation and binding free energy study.
Saravanan K; Hunday G; Kumaradhas P
J Biomol Struct Dyn; 2020 Mar; 38(4):957-974. PubMed ID: 30963817
[TBL] [Abstract][Full Text] [Related]
26. Structure-based approaches to improve selectivity: CDK2-GSK3beta binding site analysis.
Vulpetti A; Crivori P; Cameron A; Bertrand J; Brasca MG; D'Alessio R; Pevarello P
J Chem Inf Model; 2005; 45(5):1282-90. PubMed ID: 16180905
[TBL] [Abstract][Full Text] [Related]
27. Theoretical studies on the selective mechanisms of GSK3β and CDK2 by molecular dynamics simulations and free energy calculations.
Zhao S; Zhu J; Xu L; Jin J
Chem Biol Drug Des; 2017 Jun; 89(6):846-855. PubMed ID: 27863047
[TBL] [Abstract][Full Text] [Related]
28. Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites.
Ryves WJ; Dajani R; Pearl L; Harwood AJ
Biochem Biophys Res Commun; 2002 Jan; 290(3):967-72. PubMed ID: 11798168
[TBL] [Abstract][Full Text] [Related]
29. Deep insights into the mode of ATP-binding mechanism in Zebrafish cyclin-dependent protein kinase-like 1 (zCDKL1): A molecular dynamics approach.
Rout AK; Dehury B; Maharana J; Nayak C; Baisvar VS; Behera BK; Das BK
J Mol Graph Model; 2018 May; 81():175-183. PubMed ID: 29574323
[TBL] [Abstract][Full Text] [Related]
30. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
31. Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
Zhang N; Zhong R; Yan H; Jiang Y
Chem Biol Drug Des; 2011 Mar; 77(3):199-205. PubMed ID: 21244636
[TBL] [Abstract][Full Text] [Related]
32. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
33. Insights into the interactions between maleimide derivates and GSK3β combining molecular docking and QSAR.
Quesada-Romero L; Mena-Ulecia K; Tiznado W; Caballero J
PLoS One; 2014; 9(7):e102212. PubMed ID: 25010341
[TBL] [Abstract][Full Text] [Related]
34. Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.
Noël A; Barrier L; Rinaldi F; Hubert C; Fauconneau B; Ingrand S
J Neurosci Res; 2011 May; 89(5):755-63. PubMed ID: 21360572
[TBL] [Abstract][Full Text] [Related]
35. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
36. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
Ryves WJ; Harwood AJ
Biochem Biophys Res Commun; 2001 Jan; 280(3):720-5. PubMed ID: 11162580
[TBL] [Abstract][Full Text] [Related]
37. Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma.
Lu K; Wang X; Chen Y; Liang D; Luo H; Long L; Hu Z; Bao J
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):456-464. PubMed ID: 29546355
[TBL] [Abstract][Full Text] [Related]
38. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
39. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
40. Multiple alternative splicing and differential expression patterns of the glycogen synthase kinase-3β (GSK3β) gene in Schizothorax prenanti.
Wang Y; Hou Y; Zhao L; He Z; Jiang J; Li Z; Du Z; Yan T; Wang L
Comp Biochem Physiol B Biochem Mol Biol; 2015 Mar; 181():1-6. PubMed ID: 25461676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
